Forbes Regional Hospita — Monroeville, Pennsylvania

Forbes Regional Hospita is a clinical research site located in Monroeville, Pennsylvania, United States 15146.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Forbes Regional Hospita has participated in 1 clinical trials.

Therapeutic areas: Gastrointestinal Dysmotility.

Sponsors: Tranzyme, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Monroeville

Browse all research sites in Pennsylvania · View every site in Monroeville

• UPMC East Hospital
• Forbes Regional Hospital
• West Penn Hospital Forbes Campus
• Forbes Hospital
• University of Pittsburgh Medical Center
• University Cancer Institute, LLC
• AHN Forbes Hospital
• Magee-Womens Hospital of UPMC,400 Oxford Drive
• UPMC Hillman Cancer Center Monroeville
• UPMC Cancer Center Monroeville
• Retina Vitreous Consultants
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Forbes Regional Hospita?

Forbes Regional Hospita has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Forbes Regional Hospita conducted?

Forbes Regional Hospita has 1 clinical trials on record. Their work covers Gastrointestinal Dysmotility.

Is Forbes Regional Hospita accredited by Crixeo Clinical Trials?

Forbes Regional Hospita has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Forbes Regional Hospita?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.